Plasma levels of soluble CD30, tumour necrosis factor (TNF)-α and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome

Paolo Rizzardi(Riverview Psychiatric Center), Adriano Lazzarin(Vita-Salute San Raffaele University), Flavia Lillo(Vita-Salute San Raffaele University), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Mauro Malnati(Vita-Salute San Raffaele University), Giuseppe Tambussi(San Raffaele University of Rome), Luc Perrin(Riverview Psychiatric Center)
AIDS
November 1, 1996
10.1097/00002030-199611000-00001
Cited by 69

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
|Immunity|1995|574
CD46 Is a Cellular Receptor for Human Herpesvirus 6
|Cell|1999|525